Stereotactic Ablative Radiotherapy for Lung Cancer

Research output: Chapter in Book/Report/Conference proceedingChapter


Stereotactic ablative radiotherapy (SABR), historically known as stereotactic body radiation therapy (SBRT), has rapidly developed into an important tool radiation oncologists use in the treatment of lung cancers. The indications for treatment of medically inoperable lung cancers have become well established. SABR is also being evaluated more frequently in the setting of operable lung cancers, metastases from primary tumors to the lungs and other anatomic sites, and oligometastatic lung disease as well. This chapter highlights the biologic, technologic, and clinical advances that have led to the increased acceptance and use of SABR in mainstream radiation oncology practices for lung cancer.

Original languageEnglish (US)
Title of host publicationLung Cancer
Subtitle of host publicationFourth Edition
Number of pages18
ISBN (Electronic)9781118468791
ISBN (Print)9781118468746
StatePublished - May 27 2014


  • Lung cancer
  • SBRT
  • Stereotactic ablative radiotherapy
  • Stereotactic body radiation therapy

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Stereotactic Ablative Radiotherapy for Lung Cancer'. Together they form a unique fingerprint.

Cite this